These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

416 related articles for article (PubMed ID: 8866788)

  • 21. Elevation of 3'5' cyclic adenosine monophosphate alters CD3 and CD25 antigens expression in activated T lymphocytes.
    Iwaz J; Lafont S; Cordier G; Revillard JP
    J Clin Lab Immunol; 1989 Jun; 29(2):85-9. PubMed ID: 2561159
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Combination anti-CD2 and anti-CD3 monoclonal antibodies induce tolerance while altering interleukin-2, interleukin-4, tumor necrosis factor, and transforming growth factor-beta production.
    Chavin KD; Qin L; Lin J; Woodward JE; Baliga P; Bromberg JS
    Ann Surg; 1993 Oct; 218(4):492-501; discussion 501-3. PubMed ID: 8215640
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immunoregulatory functions of paf-acether. VI. Inhibition of T cell activation via CD3 and potentiation of T cell activation via CD2.
    Vivier E; Deryckx S; Wang JL; Valentin H; Peronne C; de Vries JE; Bernard A; Benveniste J; Thomas Y
    Int Immunol; 1990; 2(6):545-53. PubMed ID: 1982219
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CD2-CD48 interactions promote cytotoxic T lymphocyte induction and function: anti-CD2 and anti-CD48 antibodies impair cytokine synthesis, proliferation, target recognition/adhesion, and cytotoxicity.
    Musgrave BL; Watson CL; Hoskin DW
    J Interferon Cytokine Res; 2003 Feb; 23(2):67-81. PubMed ID: 12744772
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Role in T-cell activation for HLA class I molecules from accessory cells: further distinction between activation signals delivered to T cells via CD2 and CD3 molecules.
    Huet S; Boumsell L; Raynal B; Degos L; Dausset J; Bernard A
    Proc Natl Acad Sci U S A; 1987 Oct; 84(20):7222-6. PubMed ID: 3118361
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Involvement of protein kinase A in histamine-mediated inhibition of IL-2 mRNA expression in mouse splenocytes.
    Poluektova LY; Huggler GK; Patterson EB; Khan MM
    Immunopharmacology; 1999 Feb; 41(2):77-87. PubMed ID: 10102790
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prostaglandin E2 and the increase of intracellular cAMP inhibit the expression of interleukin 2 receptors in human T cells.
    Rincón M; Tugores A; López-Rivas A; Silva A; Alonso M; De Landázuri MO; López-Botet M
    Eur J Immunol; 1988 Nov; 18(11):1791-6. PubMed ID: 2849551
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prostaglandin E2 and other cyclic AMP-elevating agents modulate IL-2 and IL-2R alpha gene expression at multiple levels.
    Anastassiou ED; Paliogianni F; Balow JP; Yamada H; Boumpas DT
    J Immunol; 1992 May; 148(9):2845-52. PubMed ID: 1374102
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Interleukin-4 gene expression in activated human T lymphocytes is regulated by the cyclic adenosine monophosphate-dependent signaling pathway.
    Borger P; Kauffman HF; Postma DS; Vellenga E
    Blood; 1996 Jan; 87(2):691-8. PubMed ID: 8555492
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Gangliosides GD1b, GT1b, and GQ1b enhance IL-2 and IFN-gamma production and suppress IL-4 and IL-5 production in phytohemagglutinin-stimulated human T cells.
    Kanda N; Watanabe S
    J Immunol; 2001 Jan; 166(1):72-80. PubMed ID: 11123278
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Regulation by anti-CD2 monoclonal antibody of the activation of a human T cell clone induced by anti-CD3 or anti-T cell receptor antibodies.
    Yssel H; Aubry JP; de Waal Malefijt R; de Vries JE; Spits H
    J Immunol; 1987 Nov; 139(9):2850-5. PubMed ID: 2444643
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Human T-cell leukemia virus type I-induced proliferation of human immature CD2+CD3- thymocytes.
    Maguer V; Cassé-Ripoll H; Gazzolo L; Dodon MD
    J Virol; 1993 Sep; 67(9):5529-37. PubMed ID: 8102412
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Regulatory roles of adenylate cyclase and cyclic nucleotide phosphodiesterases 1 and 4 in interleukin-13 production by activated human T cells.
    Kanda N; Watanabe S
    Biochem Pharmacol; 2001 Aug; 62(4):495-507. PubMed ID: 11448460
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effect of the CD28 activation pathway on the immunosuppressive action of cyclosporine.
    Hess AD; Bright EC
    Transplantation; 1991 Jun; 51(6):1232-40. PubMed ID: 1646506
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Early immune response and regulation of IL-2 receptor subunits.
    Hughes-Fulford M; Sugano E; Schopper T; Li CF; Boonyaratanakornkit JB; Cogoli A
    Cell Signal; 2005 Sep; 17(9):1111-24. PubMed ID: 15993752
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CD3-dependent increase in cyclic AMP in human T-cells following stimulation of the CD2 receptor.
    Kvanta A; Jondal M; Fredholm BB
    Biochim Biophys Acta; 1991 Jul; 1093(2-3):178-83. PubMed ID: 1677813
    [TBL] [Abstract][Full Text] [Related]  

  • 37. 15-Deoxyspergualin inhibits interleukin 6 production in in vitro stimulated human lymphocytes.
    Borg AJ; Kumagai-Braesch M; Möller E
    Transpl Immunol; 1996 Jun; 4(2):133-43. PubMed ID: 8843590
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Curcumin blocks interleukin (IL)-2 signaling in T-lymphocytes by inhibiting IL-2 synthesis, CD25 expression, and IL-2 receptor signaling.
    Forward NA; Conrad DM; Power Coombs MR; Doucette CD; Furlong SJ; Lin TJ; Hoskin DW
    Biochem Biophys Res Commun; 2011 Apr; 407(4):801-6. PubMed ID: 21443863
    [TBL] [Abstract][Full Text] [Related]  

  • 39. PKCtheta and PKA are antagonistic partners in the NF-AT transactivation pathway of primary mouse CD3+ T lymphocytes.
    Hermann-Kleiter N; Thuille N; Pfeifhofer C; Gruber T; Schäfer M; Zitt C; Hatzelmann A; Schudt C; Leitges M; Baier G
    Blood; 2006 Jun; 107(12):4841-8. PubMed ID: 16514061
    [TBL] [Abstract][Full Text] [Related]  

  • 40. IL-27 suppresses CD28-mediated [correction of medicated] IL-2 production through suppressor of cytokine signaling 3.
    Owaki T; Asakawa M; Kamiya S; Takeda K; Fukai F; Mizuguchi J; Yoshimoto T
    J Immunol; 2006 Mar; 176(5):2773-80. PubMed ID: 16493033
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.